IL16 and myeloid sarcoma: There was no evidence for the association between IL-16 (OR, 0.96; 95% CI, 0.89–2.12; p = 0.363) and IL-17 (OR, 1.29; 95% CI, 0.95–1.74; p = 0.102) and the predisposition to MS.